1
|
Chen BK, Luna VM, Shannon ME, Hunsberger HC, Mastrodonato A, Stackmann M, McGowan JC, Rubinstenn G, Denny CA. Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior. Biol Psychiatry 2021; 90:458-472. [PMID: 34274107 PMCID: PMC9590626 DOI: 10.1016/j.biopsych.2021.04.024] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Revised: 04/13/2021] [Accepted: 04/30/2021] [Indexed: 12/13/2022]
Abstract
BACKGROUND Major depressive disorder is a common, recurrent illness. Recent studies have implicated the NMDA receptor in the pathophysiology of major depressive disorder. (R,S)-ketamine, an NMDA receptor antagonist, is an effective antidepressant but has numerous side effects. Here, we characterized a novel NMDA receptor antagonist, fluoroethylnormemantine (FENM), to determine its effectiveness as a prophylactic and/or antidepressant against stress-induced maladaptive behavior. METHODS Saline, memantine (10 mg/kg), (R,S)-ketamine (30 mg/kg), or FENM (10, 20, or 30 mg/kg) was administered before or after contextual fear conditioning in 129S6/SvEv mice. Drug efficacy was assayed using various behavioral tests. Protein expression in the hippocampus was quantified with immunohistochemistry or Western blotting. In vitro radioligand binding was used to assay drug binding affinity. Patch clamp electrophysiology was used to determine the effect of drug administration on glutamatergic activity in ventral hippocampal cornu ammonis 3 (vCA3) 1 week after injection. RESULTS Given after stress, FENM decreased behavioral despair and reduced perseverative behavior. When administered after re-exposure, FENM facilitated extinction learning. As a prophylactic, FENM attenuated learned fear and decreased stress-induced behavioral despair. FENM was behaviorally effective in both male and female mice. (R,S)-ketamine, but not FENM, increased expression of c-fos in vCA3. Both (R,S)-ketamine and FENM attenuated large-amplitude AMPA receptor-mediated bursts in vCA3, indicating a common neurobiological mechanism for further study. CONCLUSIONS Our results indicate that FENM is a novel drug that is efficacious when administered at various times before or after stress. Future work will further characterize FENM's mechanism of action with the goal of clinical development.
Collapse
Affiliation(s)
- Briana K Chen
- Doctoral Program in Neurobiology and Behavior, Columbia University, New York, New York
| | - Victor M Luna
- Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York
| | | | - Holly C Hunsberger
- Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York
| | - Alessia Mastrodonato
- Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York
| | - Michelle Stackmann
- Doctoral Program in Neurobiology and Behavior, Columbia University, New York, New York
| | - Josephine C McGowan
- Doctoral Program in Neurobiology and Behavior, Columbia University, New York, New York
| | | | - Christine A Denny
- Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc./New York State Psychiatric Institute, New York, New York; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.
| |
Collapse
|
2
|
Leal Santos S, Stackmann M, Muñoz Zamora A, Mastrodonato A, De Landri AV, Vaughan N, Chen BK, Lanio M, Denny CA. Propranolol Decreases Fear Expression by Modulating Fear Memory Traces. Biol Psychiatry 2021; 89:1150-1161. [PMID: 33766406 PMCID: PMC8201901 DOI: 10.1016/j.biopsych.2021.01.005] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 01/11/2021] [Accepted: 01/12/2021] [Indexed: 01/27/2023]
Abstract
BACKGROUND Posttraumatic stress disorder can develop after a traumatic event and results in heightened, inappropriate fear and anxiety. Although approximately 8% of the U.S. population is affected by posttraumatic stress disorder, only two drugs have been approved by the Food and Drug Administration to treat it, both with limited efficacy. Propranolol, a nonselective β-adrenergic antagonist, has shown efficacy in decreasing exaggerated fear, and there has been renewed interest in using it to treat fear disorders. METHODS Here, we sought to determine the mechanisms by which propranolol attenuates fear by utilizing an activity-dependent tagging system, ArcCreERT2 x eYFP mice. 129S6/SvEv mice were administered a 4-shock contextual fear conditioning paradigm followed by immediate or delayed context reexposures. Saline or propranolol was administered either before or after the first context reexposure. To quantify hippocampal, prefrontal, and amygdalar memory traces, ArcCreERT2 x eYFP mice were administered a delayed context reexposure with either a saline or propranolol injection before context reexposure. RESULTS Propranolol decreased fear expression only when administered before a delayed context reexposure. Fear memory traces were affected in the dorsal dentate gyrus and basolateral amygdala after propranolol administration in the ArcCreERT2 x eYFP mice. Propranolol acutely altered functional connectivity between the hippocampal, cortical, and amygdalar regions. CONCLUSIONS These data indicate that propranolol may decrease fear expression by altering network-correlated activity and by weakening the reactivation of the initial traumatic memory trace. This work contributes to the understanding of noradrenergic drugs as therapeutic aids for patients with posttraumatic stress disorder.
Collapse
Affiliation(s)
- Sofia Leal Santos
- Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene Inc/New York State Psychiatric Institute, New York, New York; Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga, Portugal
| | - Michelle Stackmann
- Neurobiology and Behavior Graduate Program, Columbia University, New York, New York
| | - Andrea Muñoz Zamora
- Division of Systems Neuroscience, Research Foundation for Mental Hygiene Inc/New York State Psychiatric Institute, New York, New York
| | - Alessia Mastrodonato
- Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene Inc/New York State Psychiatric Institute, New York, New York
| | - Allegra V De Landri
- Division of Systems Neuroscience, Research Foundation for Mental Hygiene Inc/New York State Psychiatric Institute, New York, New York; Columbia College, Columbia University, New York, New York
| | - Nick Vaughan
- Columbia College, Columbia University, New York, New York
| | - Briana K Chen
- Neurobiology and Behavior Graduate Program, Columbia University, New York, New York
| | - Marcos Lanio
- Medical Scientist Training Program, Columbia University Irving Medical Center, New York, New York; Neurobiology and Behavior Graduate Program, Columbia University, New York, New York
| | - Christine A Denny
- Department of Psychiatry, Columbia University Irving Medical Center, New York, New York; Division of Systems Neuroscience, Research Foundation for Mental Hygiene Inc/New York State Psychiatric Institute, New York, New York.
| |
Collapse
|
3
|
Cymerblit-Sabba A, Smith AS, Williams Avram SK, Stackmann M, Korgan AC, Tickerhoof MC, Young WS. Inducing Partner Preference in Mice by Chemogenetic Stimulation of CA2 Hippocampal Subfield. Front Mol Neurosci 2020; 13:61. [PMID: 32390799 PMCID: PMC7192236 DOI: 10.3389/fnmol.2020.00061] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2020] [Accepted: 03/31/2020] [Indexed: 12/28/2022] Open
Abstract
Social recognition is fundamental for social decision making and the establishment of long-lasting affiliative behaviors in behaviorally complex social groups. It is a critical step in establishing a selective preference for a social partner or group member. C57BL/6J lab mice do not form monogamous relationships, and typically do not show prolonged social preferences for familiar mice. The CA2 hippocampal subfield plays a crucial role in social memory and optogenetic stimulation of inputs to the dorsal CA2 field during a short memory acquisition period can enhance and extend social memories in mice. Here, we show that partner preference in mice can be induced by chemogenetic selective stimulation of the monosynaptic projections from the hypothalamic paraventricular nucleus (PVN) to the CA2 during the cohabitation period. Specifically, male mice spend more time in social contact, grooming and huddling with the partner compared to a novel female. Preference was not induced by prolonging the cohabitation period and allowing more time for social interactions and males to sire pups with the familiar female. These results suggest that PVN-to-CA2 projections are part of an evolutionarily conserved neural circuitry underlying the formation of social preference and may promote behavioral changes with appropriate stimulation.
Collapse
Affiliation(s)
- Adi Cymerblit-Sabba
- Section on Neural Gene Expression, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
| | - Adam S. Smith
- Section on Neural Gene Expression, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
- Neuroscience Program, Department of Pharmacology and Toxicology, School of Pharmacy, University Kansas, Lawrence, KS, United States
| | - Sarah K. Williams Avram
- Section on Neural Gene Expression, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
- Systems Neuroscience Imaging Resource, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
| | - Michelle Stackmann
- Section on Neural Gene Expression, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
- Neurobiology and Behavior Program, Columbia University, New York, NY, United States
| | - Austin C. Korgan
- Section on Neural Gene Expression, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
- Center for Alzheimer and Dementia Research, The Jackson Laboratory, Bar Harbor, ME, United States
| | - Maria C. Tickerhoof
- Neuroscience Program, Department of Pharmacology and Toxicology, School of Pharmacy, University Kansas, Lawrence, KS, United States
| | - W. Scott Young
- Section on Neural Gene Expression, National Institute of Mental Health (NIMH), National Institute of Health, Bethesda, MD, United States
| |
Collapse
|
4
|
Williams Avram SK, Lee HJ, Fastman J, Cymerblit-Sabba A, Smith A, Vincent M, Song J, Granovetter MC, Lee SH, Cilz NI, Stackmann M, Chaturvedi R, Young WS. NMDA Receptor in Vasopressin 1b Neurons Is Not Required for Short-Term Social Memory, Object Memory or Aggression. Front Behav Neurosci 2019; 13:218. [PMID: 31787886 PMCID: PMC6856057 DOI: 10.3389/fnbeh.2019.00218] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Accepted: 09/05/2019] [Indexed: 12/20/2022] Open
Abstract
The arginine vasopressin 1b receptor (Avpr1b) plays an important role in social behaviors including aggression, social learning and memory. Genetic removal of Avpr1b from mouse models results in deficits in aggression and short-term social recognition in adults. Avpr1b gene expression is highly enriched in the pyramidal neurons of the hippocampal cornu ammonis 2 (CA2) region. Activity of the hippocampal CA2 has been shown to be required for normal short-term social recognition and aggressive behaviors. Vasopressin acts to enhance synaptic responses of CA2 neurons through a NMDA-receptor dependent mechanism. Genetic removal of the obligatory subunit of the NMDA receptor (Grin1) within distinct hippocampal regions impairs non-social learning and memory. However, the question of a direct role for NMDA receptor activity in Avpr1b neurons to modulate social behavior remains unclear. To answer this question, we first created a novel transgenic mouse line with Cre recombinase knocked into the Avpr1b coding region to genetically target Avpr1b neurons. We confirmed this line has dense Cre expression throughout the dorsal and ventral CA2 regions of the hippocampus, along with scattered expression within the caudate-putamen and olfactory bulb (OB). Conditional removal of the NMDA receptor was achieved by crossing our line to an available floxed Grin1 line. The resulting mice were measured on a battery of social and memory behavioral tests. Surprisingly, we did not observe any differences between Avpr1b-Grin1 knockout mice and their wildtype siblings. We conclude that mice without typical NMDA receptor function in Avpr1b neurons can develop normal aggression as well as short-term social and object memory performance.
Collapse
Affiliation(s)
- Sarah K Williams Avram
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.,Systems Neuroscience Imaging Resource, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Heon-Jin Lee
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.,Department of Microbiology and Immunology, School of Dentistry, Kyungpook National University, Daegu, South Korea
| | - Jarrett Fastman
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Adi Cymerblit-Sabba
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Adam Smith
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.,Neuroscience Program, Department of Pharmacology & Toxicology, University of Kansas, Lawrence, KS, United States
| | - Matthew Vincent
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - June Song
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Michael C Granovetter
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Su-Hyun Lee
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Nicholas I Cilz
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Michelle Stackmann
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - Rahul Chaturvedi
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| | - W Scott Young
- Section on Neural Gene Expression, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
| |
Collapse
|
5
|
Bartholomew RA, Li H, Gaidis EJ, Stackmann M, Shoemaker CT, Rossi MA, Yin HH. Striatonigral control of movement velocity in mice. Eur J Neurosci 2016; 43:1097-110. [PMID: 27091436 DOI: 10.1111/ejn.13187] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Accepted: 01/21/2016] [Indexed: 11/28/2022]
Abstract
The basal ganglia have long been implicated in action initiation. Using three-dimensional motion capture, we quantified the effects of optogenetic stimulation of the striatonigral (direct) pathway on movement kinematics. We generated transgenic mice with channelrhodopsin-2 expression in striatal neurons that express the D1-like dopamine receptor. With optic fibres placed in the sensorimotor striatum, an area known to contain movement velocity-related single units, photo-stimulation reliably produced movements that could be precisely quantified with our motion capture programme. A single light pulse was sufficient to elicit movements with short latencies (< 30 ms). Increasing stimulation frequency increased movement speed, with a highly linear relationship. These findings support the hypothesis that the sensorimotor striatum is part of a velocity controller that controls rate of change in body configurations.
Collapse
Affiliation(s)
- Ryan A Bartholomew
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
| | - Haofang Li
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
| | - Erin J Gaidis
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
| | - Michelle Stackmann
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
| | | | - Mark A Rossi
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
| | - Henry H Yin
- Department of Psychology and Neuroscience, Duke University, Durham, NC, USA.,Department of Neurobiology, Duke University, Durham, NC, USA.,Center for Cognitive Neuroscience, Duke University, Durham, NC, USA
| |
Collapse
|